End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
4,550
KRW
|
+1.45%
|
|
+2.59%
|
-6.57%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
48,345
|
72,895
|
64,001
|
60,077
|
59,031
|
43,313
|
Enterprise Value (EV)
1 |
59,486
|
88,747
|
80,591
|
73,996
|
65,646
|
44,723
|
P/E ratio
|
10.5
x
|
12.7
x
|
18
x
|
17.6
x
|
11.3
x
|
13.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.17
x
|
1.63
x
|
1.73
x
|
1.5
x
|
1.28
x
|
0.85
x
|
EV / Revenue
|
1.44
x
|
1.98
x
|
2.18
x
|
1.85
x
|
1.42
x
|
0.88
x
|
EV / EBITDA
|
8.15
x
|
8.65
x
|
11.1
x
|
9.53
x
|
6.4
x
|
5.04
x
|
EV / FCF
|
-10.7
x
|
-19.9
x
|
-82.5
x
|
31.8
x
|
9.35
x
|
6.46
x
|
FCF Yield
|
-9.37%
|
-5.03%
|
-1.21%
|
3.14%
|
10.7%
|
15.5%
|
Price to Book
|
0.93
x
|
1.39
x
|
1.15
x
|
1.04
x
|
0.94
x
|
0.61
x
|
Nbr of stocks (in thousands)
|
9,582
|
8,894
|
8,894
|
8,894
|
8,894
|
8,894
|
Reference price
2 |
5,045
|
8,196
|
7,196
|
6,755
|
6,637
|
4,870
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
41,389
|
44,747
|
36,972
|
40,002
|
46,285
|
51,101
|
EBITDA
1 |
7,298
|
10,257
|
7,273
|
7,764
|
10,263
|
8,873
|
EBIT
1 |
5,023
|
7,747
|
4,140
|
4,087
|
6,506
|
5,031
|
Operating Margin
|
12.14%
|
17.31%
|
11.2%
|
10.22%
|
14.06%
|
9.84%
|
Earnings before Tax (EBT)
1 |
4,964
|
6,974
|
3,265
|
4,280
|
6,430
|
3,688
|
Net income
1 |
4,504
|
5,945
|
3,648
|
3,514
|
5,384
|
3,425
|
Net margin
|
10.88%
|
13.29%
|
9.87%
|
8.78%
|
11.63%
|
6.7%
|
EPS
2 |
482.3
|
646.0
|
398.9
|
384.1
|
588.9
|
365.0
|
Free Cash Flow
1 |
-5,576
|
-4,466
|
-976.5
|
2,324
|
7,018
|
6,928
|
FCF margin
|
-13.47%
|
-9.98%
|
-2.64%
|
5.81%
|
15.16%
|
13.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
29.94%
|
68.38%
|
78.08%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
66.14%
|
130.35%
|
202.26%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
11,141
|
15,852
|
16,590
|
13,919
|
6,615
|
1,410
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.527
x
|
1.545
x
|
2.281
x
|
1.793
x
|
0.6446
x
|
0.1589
x
|
Free Cash Flow
1 |
-5,576
|
-4,466
|
-976
|
2,324
|
7,018
|
6,928
|
ROE (net income / shareholders' equity)
|
9.27%
|
11.4%
|
6.56%
|
6.02%
|
8.65%
|
4.83%
|
ROA (Net income/ Total Assets)
|
4.54%
|
6.25%
|
3.09%
|
3.03%
|
4.78%
|
3.52%
|
Assets
1 |
99,184
|
95,143
|
117,897
|
116,035
|
112,542
|
97,243
|
Book Value Per Share
2 |
5,437
|
5,917
|
6,244
|
6,521
|
7,094
|
8,026
|
Cash Flow per Share
2 |
511.0
|
581.0
|
728.0
|
635.0
|
1,185
|
903.0
|
Capex
1 |
9,449
|
7,812
|
2,296
|
719
|
1,025
|
2,366
|
Capex / Sales
|
22.83%
|
17.46%
|
6.21%
|
1.8%
|
2.22%
|
4.63%
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -6.57% | 29.24M | | +13.43% | 64.66B | | -3.80% | 46.08B | | +13.26% | 39.72B | | +20.24% | 25.82B | | +8.22% | 18.8B | | -0.60% | 17.14B | | -21.03% | 15.86B | | +1.06% | 15.05B | | -17.64% | 14.14B |
Other Specialty Chemicals
|